Skip to main content

Headline Roundup March 22nd, 2021

AstraZeneca Says Its COVID-19 Vaccine is 79% Effective

Summary from the AllSides News Team

In U.S. clinical trials, AstraZeneca said its COVID-19 vaccine was shown to be safe and 79% effective in preventing symptomatic disease, providing a vote of confidence for the shot and a pathway for its authorization by the Food and Drug Administration (FDA). The company said it would continue to analyze the data and prepare to request emergency authorization in the U.S. in coming weeks. If approved by the FDA, the vaccine could be available as early as next month, joining three other approved shots in America’s accelerating vaccine rollout.

Featured Coverage of this Story

AstraZeneca’s U.S. trial shows coronavirus vaccine is 79 percent effective
AstraZeneca’s U.S. trial shows coronavirus vaccine is 79 percent effective

Washington Post

News

Oxford University and AstraZeneca reported on Monday that their coronavirus "vaccine for the world" was safe and 79 percent effective overall, according to data from a long-awaited clinical trial in the United States, alongside other studies in Chile and Peru. The two-shot regimen was completely effective at preventing severe cases of illness.

In a news release, the Oxford researchers, who developed the easily transported $4 shot for the British-Swedish pharmaceutical giant AstraZeneca, said their coronavirus vaccine is “safe and highly effective, adding to previous trial data from the United Kingdom,...

Open on Washington Post
AstraZeneca: US data shows vaccine effective for all adults
AstraZeneca: US data shows vaccine effective for all adults

Associated Press

News

AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease, including in older adults, in final-stage U.S. testing, the company announced Monday.

AstraZeneca said its experts did not identify any safety concerns related to the vaccine, including finding no increased risk of rare blood clots identified in Europe. The question now is whether the findings will help rebuild public confidence in the vaccine around the world, as the company seeks to win clearance in the United States

In a statement, AstraZeneca said its COVID-19...

Open on Associated Press
AstraZeneca COVID-19 vaccine 100% effective at preventing hospitalizations, company says
AstraZeneca COVID-19 vaccine 100% effective at preventing hospitalizations, company says

Washington Examiner

News

New data from AstraZeneca’s coronavirus vaccine trial, which has yet to receive emergency authorization in the United States, is showing positive results.

The latest data from the company published on Monday showed that the vaccine has an efficacy of 79% at preventing symptomatic cases of the coronavirus while being 100% effective at stopping severe disease and hospitalization. The trial included 32,449 participants, and a fifth of them, approximately 8,000 people, were 65 years old or older. 60% of study participants have comorbidities that make them more at risk for a...

Open on Washington Examiner

More headline roundups

More News about Coronavirus on AllSides

News from the Left

News from the Center

News from the Right